Eligible patients with commercial insurance pay $0 each time you fill your prescription.*

*With a $7,500 maximum program benefit per calendar year. Not valid for patients using Medicare, Medicaid, or other government-funded programs to pay for their medications. Terms expire at the end of each calendar year and may change. There is no income requirement. See full eligibility requirements.

Learn about Financial Support

What is EDURANT^® (rilpivirine)?

What are EDURANT^® (rilpivirine) and EDURANT^® PED?

EDURANT^® and EDURANT^® PED are prescription medicines that are used with:

• other human immunodeficiency virus-1 (HIV-1) medicines to treat HIV-1 infection in people 2 years of age and older and who weigh at least 31 pounds (lbs) or 14 kilograms (kg) who:

  Human Immunodeficiency Virus (HIV):

  The virus that causes AIDS.
  • have never taken HIV-1 medicines before, and
  • have an amount of HIV-1 in their blood (this is called ‘viral load’) that is no more than 100,000 copies/mL.
• EDURANT^® is also used with oral VOCABRIA (cabotegravir) for short term treatment of HIV-1 infection in people 12 years of age or older and who weigh at least 77 lbs (35 kg) when their healthcare provider determines that they meet certain requirements.

HIV-1 is the virus that causes AIDS (Acquired Immune Deficiency Syndrome).

If you take EDURANT^® in combination with oral VOCABRIA (cabotegravir), you should also read the Patient Information that comes with oral VOCABRIA (cabotegravir).

It is not known if EDURANT^® or EDURANT^® PED is safe and effective in children less than 2 years of age or who weigh less than 31 lbs (14 kg).